Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (151-160 of 368) with videos related to

Pageof 37
Sort By:
The Lancet. Public Health|August 30, 2024
Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysisChristel Macdonald, Georgina Macpherson, Oscar Leppan, et al.
Journal of Hepatology|August 9, 2015
Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?Jason Grebely, Bridget Haire, Lynn E Taylor, et al.
The International Journal on Drug Policy|January 26, 2018
Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p studyEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Canadian Liver Journal|August 22, 2022
6th Canadian Symposium on Hepatitis C Virus: Delivering a cure for hepatitis C infection-What are the remaining gaps?Sarwat Khan, Annie Bernier, Dustin Dapp, et al.
Scientific Reports|February 1, 2017
Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatmentAuda A Eltahla, Preston Leung, Mehdi R Pirozyan, et al.
The International Journal on Drug Policy|April 1, 2023
'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinueSimon Clay, Carla Treloar, Louisa Degenhardt, et al.
Journal of Medical Virology|July 22, 2014
Dynamics of HCV RNA levels during acute hepatitis C virus infectionBehzad Hajarizadeh, Jason Grebely, Tanya Applegate, et al.
Journal of Viral Hepatitis|September 30, 2018
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling studyJisoo A Kwon, Gregory J Dore, Jason Grebely, et al.
Drug and Alcohol Review|December 23, 2025
Navigating the Gap: An Examination of Funder Rhetoric and Reality Regarding Community-Research PartnershipsDanielle M Russell, Ele Morrison, Jason Grebely, et al.
Drug and Alcohol Review|April 17, 2024
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage StudyAbdullah Farooq, Heather Valerio, Alice Wheeler, et al.
Pageof 37

Showing results (151-160 of 368) with videos related to

Sort By:
Pageof 37
The Lancet. Public Health|August 30, 2024
Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysisChristel Macdonald, Georgina Macpherson, Oscar Leppan, et al.
Journal of Hepatology|August 9, 2015
Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?Jason Grebely, Bridget Haire, Lynn E Taylor, et al.
The International Journal on Drug Policy|January 26, 2018
Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p studyEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Canadian Liver Journal|August 22, 2022
6th Canadian Symposium on Hepatitis C Virus: Delivering a cure for hepatitis C infection-What are the remaining gaps?Sarwat Khan, Annie Bernier, Dustin Dapp, et al.
Scientific Reports|February 1, 2017
Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatmentAuda A Eltahla, Preston Leung, Mehdi R Pirozyan, et al.
The International Journal on Drug Policy|April 1, 2023
'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinueSimon Clay, Carla Treloar, Louisa Degenhardt, et al.
Journal of Medical Virology|July 22, 2014
Dynamics of HCV RNA levels during acute hepatitis C virus infectionBehzad Hajarizadeh, Jason Grebely, Tanya Applegate, et al.
Journal of Viral Hepatitis|September 30, 2018
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling studyJisoo A Kwon, Gregory J Dore, Jason Grebely, et al.
Drug and Alcohol Review|December 23, 2025
Navigating the Gap: An Examination of Funder Rhetoric and Reality Regarding Community-Research PartnershipsDanielle M Russell, Ele Morrison, Jason Grebely, et al.
Drug and Alcohol Review|April 17, 2024
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage StudyAbdullah Farooq, Heather Valerio, Alice Wheeler, et al.
Pageof 37